Daiichi Sankyo to launch COVID-19 vaccine in Japan in 2022

Economy Society

Japanese drugmaker Daiichi Sankyo Co. said Thursday it expects to launch its COVID-19 vaccine in Japan by the end of 2022 after studies that started in March yielded positive results. The company plans to next month accelerate the pace of the trial, aiming to begin by March the final stage of study on its messenger RNA vaccine, the same type already developed by overseas companies including Pfizer Inc. and Moderna Inc. The trial conducted on 142 people aged 20 or older confirmed vaccine-induced antibody responses, with no safety issues observed, Daiichi Sankyo said. It also was shown to inhibi...

Kyodo News

Kyodo News Society